GLP-1 T

Weight Loss Peptide

GLP-1 T

4.7 (156 reviews)

Synthetic peptide commonly studied for its role in cellular repair mechanisms involving connective tissue, muscle, tendon, and gastrointestinal systems.

1
$79.99
Most Popular
Best Value
Est. delivery May 18 - May 20
Free shipment protection
Secure checkout
We accept: Visa Mastercard American Express
Free shipping on orders over $200
Damage protection on every order
Secure checkout 256-bit SSL
Certificate of Analysis
Tested for Identification, Purity, Mass, Endotoxins, Sterility, and Heavy Metals
LATEST SELECTED DOSAGE
99.47%
PURITY
Variant GLP-1 T 10MG
Lot # TRZ-2601-A01
Labeled 10mg
Actual 10.83mg
Tested March 07, 2026
LATEST
99.33%
PURITY
Variant GLP-1 T 20MG
Lot # TRZ-2601-A02
Labeled 20mg
Actual 21.25mg
Tested March 06, 2026
LATEST
99.71%
PURITY
Variant GLP-1 T 30MG
Lot # TRZ-2601-B01
Labeled 30mg
Actual 32.64mg
Tested March 07, 2026
LATEST
99.58%
PURITY
Variant GLP-1 T 60MG
Lot # TRZ-2601-B01
Labeled 60mg
Actual 61.75mg
Tested March 07, 2026
LATEST
99.29%
PURITY
Variant GLP-1 T 100MG
Lot # TRZ-2601-B03
Labeled 100mg
Actual 103.98mg
Tested March 07, 2026
LATEST
99.44%
PURITY
Variant GLP-1 T 120MG
Lot # TRZ-2601-B04
Labeled 120mg
Actual 123.72mg
Tested March 07, 2026
Compound Information
Pharmaceutical Specifications
Molecular Profile
What Is GLP-1 T?
TypeSynthetic peptide
CAS Number2023788-19-2
Molecular FormulaC₂₂₅H₃₄₈N₄₈O₆₈
Molecular Weight4,813.47 g/mol
Amino Acids39
PubChem Database
Storage Requirements
Stability Information
Freeze for storage Refrigerate after reconstitution Protect from light
Lyophilized (powder)
-20°C  ·  24+ months
Reconstituted
2-8°C  ·  ~30 days
Research
Sources & References
NEW ENGLAND JOURNAL OF MEDICINE
Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)
2022  ·  DOI: 10.1056/NEJMoa2206038
Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al.
View Source
NEW ENGLAND JOURNAL OF MEDICINE
Tirzepatide for Obesity Treatment and Diabetes Prevention — 3-Year SURMOUNT-1 Extension
2024  ·  DOI: 10.1056/NEJMoa2410819
Jastreboff AM, le Roux CW, Stefanski A, Aronne LJ, Halpern B, Wharton S, et al.
View Source
NEW ENGLAND JOURNAL OF MEDICINE
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5)
2025  ·  DOI: 10.1056/NEJMoa2416394
Wadden TA, Chao AM, Machineni S, Kushner RF, Stanwyck C, Srivastava G, et al.
View Source
NEW ENGLAND JOURNAL OF MEDICINE
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity (SUMMIT Trial)
2024  ·  DOI: 10.1056/NEJMoa2410027
Packer M, Zile MR, Kramer CM, Baum SJ, Litwin SE, Menon V, et al.
View Source
NEW ENGLAND JOURNAL OF MEDICINE
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA)
2024  ·  DOI: 10.1056/NEJMoa2404881
Malhotra A, Grunstein RR, Fietze I, Weaver TE, Redline S, Azarbarzin A, et al.
View Source
NEW ENGLAND JOURNAL OF MEDICINE
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes (SURPASS-CVOT)
2025  ·  DOI: 10.1056/NEJMoa2505928
Nicholls SJ, et al.
View Source
THE LANCET
Efficacy and Safety of a Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide in Patients with Type 2 Diabetes (SURPASS-1)
2021  ·  DOI: 10.1016/S0140-6736(21)01324-6
Rosenstock J, Wysham C, Frías JP, Kaneko S, Lee CJ, Landó LF, et al.
View Source
NEW ENGLAND JOURNAL OF MEDICINE
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2)
2021  ·  DOI: 10.1056/NEJMoa2107519
Frías JP, Davies MJ, Rosenstock J, Pérez Manghi FC, Fernández Landó L, Bergman BK, et al.
View Source
NATURE MEDICINE
Tirzepatide Cardiovascular Event Risk Assessment: A Pre-Specified Meta-Analysis
2022  ·  DOI: 10.1038/s41591-022-01707-4
Sattar N, McGuire DK, Pavo I, Weerakkody GJ, Nishiyama H, Wiese RJ, et al.
View Source
CIRCULATION (AHA)
Effects of Tirzepatide on the Clinical Trajectory of Patients with Heart Failure, Preserved Ejection Fraction, and Obesity (SUMMIT)
2025  ·  DOI: 10.1161/CIRCULATIONAHA.124.072679
Borlaug BA, Packer M, Zile MR, Kramer CM, Menon V, et al.
View Source

Weight Loss Peptide

Synthetic peptide commonly studied for its role in cellular repair mechanisms involving connective tissue, muscle, tendon, and gastrointestinal systems.

Additional information

Quantity:

10MG, 10MG (Three Vials), 20MG, 20MG (Three Vials), 30MG, 30MG (Three Vials), 60MG, 60MG (Three Vials), 100MG, 100MG (Three Vials), 120MG, 120MG (Three Vials)

You May Also Like